InvestSMART

Carnegie Clean Energy Limited (ASX: CCE) - Announcements

Current share price for CCE : $0.155 0.005 (3.33%)+

ASX company news and announcements for Carnegie Clean Energy Limited (CCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Carnegie Clean Energy Limited (CCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Carnegie Clean Energy Limited (CCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Carnegie Clean Energy Limited (CCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$66 Ceasing to be a substantial holder 14 Dec 2016 10:01AM $0.097 $0.155 risen by 59.79%
$66 New Name and Strategy - Avita Medical Limited 6 May 2008 8:23AM $0.012 $0.155 risen by 1,191.67%
$66 Appendix 4C - quarterly 30 Apr 2008 8:29AM $0.013 $0.155 risen by 1,092.31%
$66 Half Year Report and Accounts 29 Feb 2008 8:26AM $0.016 $0.155 risen by 868.75%
$66 MERGER COMPLETION 12 Feb 2008 2:33PM $0.025 $0.155 risen by 520%
$66 Appendix 4C - quarterly 30 Jan 2008 8:31AM $0.022 $0.155 risen by 604.55%
$66 Appendix 4C - quarterly 30 Oct 2007 8:28AM $0.033 $0.155 risen by 369.70%
$66 C3 to merge with Visiomed 10 Oct 2007 9:52AM $0.035 $0.155 risen by 342.86%
$66 Trading Halt 9 Oct 2007 9:41AM $0.034 $0.155 risen by 355.88%
$66 Preliminary Final Report 31 Aug 2007 8:28AM $0.038 $0.155 risen by 307.89%
$66 Appendix 4C - quarterly 27 Jul 2007 8:29AM $0.036 $0.155 risen by 330.56%
$66 Commitments Test Entity - Third Quarter Report 27 Apr 2007 8:33AM $0.045 $0.155 risen by 244.44%
$66 Strategic Review 29 Mar 2007 9:29AM $0.061 $0.155 risen by 154.10%
$66 Half Yearly Report/Half Year Accounts 27 Feb 2007 8:27AM $0.074 $0.155 risen by 109.46%
$66 Revised Sales Forecasts 19 Feb 2007 8:26AM $0.090 $0.155 risen by 72.22%
$66 Commitments Test Entity - Second Quarter Report 30 Jan 2007 8:30AM $0.130 $0.155 risen by 19.23%
$66 SPP Oversubscribed & Additional Placement 7 Dec 2006 8:30AM $0.115 $0.155 risen by 34.78%
$66 Update on US approval for ReCell 27 Nov 2006 8:30AM $0.135 $0.155 risen by 14.81%
$66 Response to ASX Query re: Share Price 23 Nov 2006 3:44PM $0.135 $0.155 risen by 14.81%
$66 ReCell Clinical Update 14 Nov 2006 8:30AM $0.092 $0.155 risen by 68.48%
$66 CellSpray approved in Greece 8 Nov 2006 8:29AM $0.085 $0.155 risen by 82.35%
$66 Commitments Test Entity - First Quarter Report 31 Oct 2006 8:28AM $0.084 $0.155 risen by 84.52%
$66 Underwritten Share Purchase Plan 25 Oct 2006 9:38AM $0.088 $0.155 risen by 76.14%
$66 Supply Agreement 28 Sep 2006 8:30AM $0.097 $0.155 risen by 59.79%
$66 Preliminary Final Report 7 Sep 2006 8:29AM $0.096 $0.155 risen by 61.46%

576 - 600 of 642 results

Page 24 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.